Testing the “read-across hypothesis” by investigating the effects of ibuprofen on fish  by Patel, Alpa et al.
lable at ScienceDirect
Chemosphere 163 (2016) 592e600Contents lists avaiChemosphere
journal homepage: www.elsevier .com/locate/chemosphereTesting the “read-across hypothesis” by investigating the effects of
ibuprofen on ﬁsh
Alpa Patel a, Grace H. Panter b, 1, Henry T. Trollope b, 2, Yohanna C. Glennon b,
Stewart F. Owen b, 3, John P. Sumpter c, *, Mariann Rand-Weaver a
a Biosciences, Institute of Environment, Health and Societies, Brunel University London, Uxbridge, Middlesex, UB8 3PH, United Kingdom
b AstraZeneca, Brixham Environmental Laboratory, Freshwater Quarry, Brixham, Devon, TQ5 8BA, United Kingdom
c Institute of Environment, Health and Societies, Brunel University London, Uxbridge, Middlesex, UB8 3PH, United Kingdomh i g h l i g h t s Study provides evidence for the “read-across hypothesis”.
 Ibuprofen decreased “prostaglandin E metabolite” (PGEM) levels in fathead minnows.
 “Mode-of-action” response seen in ﬁsh at plasma concentrations similar to the Cmax.
 Large inter-individual variation in plasma ibuprofen and PGEM levels observed.a r t i c l e i n f o
Article history:
Received 2 June 2016
Received in revised form
2 August 2016
Accepted 8 August 2016
Available online 28 August 2016
Handling Editor: Shane Snyder
Keywords:
Ibuprofen
Biological read-across
Blood plasma
Prostaglandin E metabolite
Gene expression* Corresponding author.
E-mail address: John.Sumpter@Brunel.ac.uk (J.P. S
1 Present address. Grace H. Panter; Syngenta Envir
Research Centre, Bracknell, Berkshire, RG42 6EY, UK.
2 Present address. Henry T. Trollope; Torbay Pharm
Devon NHS Foundation Trust, Wilkins Drive, Paignton
3 Present address. Stewart F. Owen; AstraZeneca, G
Park, Macclesﬁeld, Cheshire, SK10 4TF, UK.
http://dx.doi.org/10.1016/j.chemosphere.2016.08.041
0045-6535/© 2016 The Authors. Published by Elseviea b s t r a c t
Human pharmaceuticals present in the environment have the potential to cause adverse effects on non-
target organisms. The “read-across hypothesis” stipulates that pharmaceuticals will exhibit similar
biological effects across species (e.g. human and ﬁsh) if the molecular target has been conserved and the
effective drug concentrations are reached (Cmax). We tested this hypothesis by evaluating if ibuprofen, a
non-selective inhibitor of prostaglandins and the cyclooxygenase (COX) enzyme, can mimic its primary
effect in humans, on ﬁsh, at comparable plasma concentrations. The endpoints, prostaglandin E
metabolite (PGEM) levels and the mRNA expression of COX (ptgs) gene, were measured in the gills of
control and exposed fathead minnows (Pimephales promelas), using enzyme-immunoassay and quanti-
tative real-time PCR (qPCR). Fish were exposed, for 24e72 h, to measured water concentrations of 9
(n ¼ 12), 370 (n ¼ 40) and 470 mg ibuprofen/L (n ¼ 12). Water and blood plasma concentrations were
determined using LC-MS/MS. Results showed that PGEM levels in ﬁsh exposed to 370 and 470 mg
ibuprofen/L were signiﬁcantly decreased compared to control ﬁsh, when mean plasma ibuprofen con-
centrations were 1.8e5.6-fold below the Cmax. The plasma ibuprofen concentrations and PGEM levels
varied greatly between individuals. In ﬁsh exposed to 9 mg ibuprofen/L, when the mean plasma ibuprofen
concentration was 224-fold below Cmax, no change in PGEM levels was observed. These data provide
evidence for the read-across hypothesis, but suggest establishing a direct dose-response between in-
ternal plasma and PGEM is difﬁcult, and would require signiﬁcantly larger numbers of ﬁsh to overcome
the inter-individual variation.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).umpter).
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The presence of pharmaceuticals in the aquatic environment,
and their real and potential effects on living organisms, have
become major research topics. One important issue to resolve is
how best to prioritize pharmaceuticals, so that research is focused
on those that present the greatest risk to living organisms. Various
strategies have been proposed (Roos et al., 2012). One strategy is toe under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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concentrations of wildlife, such as ﬁsh, are to the effective drug
concentrations in humans, provided that the molecular drug target
(i.e. receptor or enzyme) has been conserved: this is the basis of the
read-across hypothesis (Huggett et al., 2003; Rand-Weaver et al.,
2013; Tanoue et al., 2015). Currently, little information is available
to support the use of the read-across hypothesis to predict the
environmental (e.g. river) concentrations of pharmaceuticals that
will cause effects to ﬁsh. A recent publication (Margiotta-Casaluci
et al., 2014) has shown that the anti-depressant ﬂuoxetine affects
behavior of ﬁsh only when their plasma concentration is within the
human therapeutic range. However, the range of ﬂuoxetine con-
centrations reported to affect various species of aquatic organisms
is very wide (Sumpter et al., 2014), suggesting that the read-across
hypothesis may not be universally applicable. To assess the
robustness of the read-across hypothesis, we investigated the up-
take of the human pharmaceutical ibuprofen by ﬁsh and the in-
ternal (blood plasma) concentrations required to elicit a mode-of-
action related effect.
Ibuprofen is a non-selective inhibitor of the cyclooxygenase
(COX) enzyme. There are two mammalian isoforms, COX 1 and COX
2, which are encoded by the ptgs 1 and ptgs 2 genes, respectively.
During inﬂammation, the COX 2 enzyme is rapidly induced,
increasing the biosynthesis of prostanoids, primarily prostaglandin
E2 (PGE2). PGE2 has been identiﬁed in teleost ﬁsh species (e.g.
zebraﬁsh [Danio rerio] (Grosser et al., 2002; Morthorst et al., 2013);
rainbow trout [Oncorhynchus mykiss] (Knight et al., 1995) and
bluntnose minnow [Pimephales notatus] (Bhandari and Venables,
2011)), suggesting that the human drug target is conserved in ﬁsh.
Ibuprofen is a widely prescribed non-steroidal anti-inﬂamma-
tory drug (NSAID), frequently detected in both wastewater efﬂu-
ents and rivers (Hughes et al., 2013; Osorio et al., 2015), typically in
the low mg/L to ng/L range. There is an increasing body of evidence
showing the potential for NSAIDs to perturb physiological pro-
cesses in aquatic vertebrates, such as cortisol synthesis and
osmoregulation (Gravel et al., 2009; Gravel and Vijayan, 2007),
hematological changes (Saravanan et al., 2012) and ﬁsh reproduc-
tion and development (David and Pancharatna, 2009; Flippin et al.,
2007). Recent studies, investigating possible effects of ibuprofen on
ﬁsh, have suggested that adverse effects on the reproductive axis
occur at concentrations of less than or equal to 0.1 mg/L (Ji et al.,
2013) which, if repeatable, would indicate that ibuprofen poses a
signiﬁcant threat to populations of wild ﬁsh.
We tested the read-across hypothesis, by determining if
ibuprofen inhibits PGE2 synthesis in ﬁsh, mimicking its primary
effect in humans, and if so, at what water concentration. Water and
plasma concentrations of ibuprofen were measured, as well as gill
prostaglandin metabolite levels. By doing so, we assessed the val-
idity of the read-across hypothesis as a means of predicting the
water concentration of a pharmaceutical required to induce the
anticipated mode-of-action related effect. We also included awater
concentration that was not expected to produce the effective
plasma concentrations in ﬁsh, in order to fully validate the read-
across hypothesis.
2. Materials and methods
2.1. Fish husbandry
Adult (4e6 months), all male, fathead minnows were bred and
held at AstraZeneca's Brixham Environmental Laboratory (Devon,
UK), under a ﬂow-through system at a water temperature of
25 ± 1 C and a 16:8 light/dark photoperiod. Fish were fed (before
exposures) twice daily with food pellet (Biomar, Brande, Denmark)
and frozen adult brine shrimp (Artemia sp.). Work was conductedunder license granted by the UK Home Ofﬁce under the Animals
(Scientiﬁc Procedures) Act 1986.
2.2. Test chemicals
Ibuprofen (98% purity, CAS:15687-27-1) was purchased from
Sigma-Aldrich (Dorset, UK) and stored at room temperature.
Ibuprofen stock solutions were prepared in acetone (CAS No. 67-
64-1; 99% purity; Fisher Scientiﬁc, Loughborough, UK). Dech-
lorinated mains water (dilution water) was used to dilute the
ibuprofen stock solutions to nominal test concentrations (5, 100,
270, 350, 370 and 500 mg/L) in glass tanks with aworking volume of
45 L. A solvent control (SC) was also included. The acetone con-
centrationwas maintained at 0.0016% and therefore did not exceed
0.01%, as recommended by OECD guidelines (OECD, 1992).
2.3. Ibuprofen experiments
A (two-part) range-ﬁnder was conducted to assess the uptake of
ibuprofen into ﬁsh blood plasma and to establish the water con-
centration(s) required to produce human therapeutic plasma con-
centrations (Cmax) in ﬁsh. Fathead minnows (n ¼ 96; (wet) weight:
2.89 ± 0.53 g; (standard) length: 52.6 ± 4.04 mm) were ﬁrst
exposed, over 3e96 h, to SC (n ¼ 16) and nominal water concen-
trations of 100 and 500 mg ibuprofen/L (n ¼ 16 per concentration),
using continuous ﬂow-through conditions, and sampled (n ¼ 4)
after 3, 24, 48 and 96 h. In the second part, fathead minnows were
exposed, over 24e96 h, to SC (n ¼ 16) and nominal water con-
centrations of 270 and 370 mg ibuprofen/L, using continuous ﬂow-
through conditions, and sampled (n ¼ 4) after 24, 48, 72 and 96 h.
Following the results of the range-ﬁnder, a suitable water
(exposure) concentration was selected (one which was expected to
produce ﬁsh plasma concentrations close to the Cmax) in order to
examine prostaglandin metabolite levels in ﬁsh. Using a larger
sample size, fathead minnows (n ¼ 50; weight: 2.94 ± 0.80 g;
length: 53.9 ± 4.27 mm) were exposed to SC (n ¼ 10) and the
nominal water concentration of 350 mg ibuprofen/L (n ¼ 40) for
72 h, using continuous ﬂow-through conditions, and then sampled.
In a third (smaller) experiment, designed to test the hypothesis
that a low concentration of ibuprofen (one that would produce a
ﬁsh plasma concentrationwell below the Cmax) would not cause an
effect on prostaglandin metabolite levels, fathead minnows
(n ¼ 45; weight ¼ 2.74 ± 0.47 g; length ¼ 50.9 ± 4.03 mm) were
exposed for 24e72 h to SC (n ¼ 9) and nominal water concentra-
tions of 5 mg ibuprofen/L (n ¼ 18) or 350 mg ibuprofen/L (n ¼ 18),
using static conditions. The 5 mg/L concentration was not expected
to produce the effective plasma concentrations in ﬁsh and the
350 mg/L was included to test the repeatability of the results of the
earlier experiment. Fish were sampled after 24, 48 and 72 h (SC,
n¼ 3; 5 mg/L, n¼ 6; and 350 mg/L, n¼ 6 at each time point). A static
renewal design was used because it is much easier, uses lesser
amounts of test chemical (ibuprofen) and is more cost-effective
than it is to run a ﬂow-through experiment. However, under ideal
conditions, a ﬂow-through would have been used.
2.4. Exposure conditions and water sampling
The dilution water was maintained at 25 ± 1 C, dissolved ox-
ygen (DO)80% air saturation and pH at 7.4 ± 1. For the continuous
ﬂow-through regime, dilution water ﬂowed into glass mixing
vessels at a rate of 250 mL/min, and also received the stock test
solution (via a syringe) at a rate of 0.004mL/min in order to achieve
the desired concentration in the tank. Separate glass lines from
each mixing vessel supplied to the tank produced eight tank vol-
ume changes per day, which subsequently went to waste. For the
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directly into the tanks at the beginning of the exposure. Tempera-
ture, pH, DO, alkalinity, hardness and conductivity were measured
twice during the exposures. Fish were subjected to a 16:8 h
(light:dark) photoperiod, with a 20 min dawn/dusk transition
period and were not fed during the exposures. The water concen-
tration of ibuprofen was measured daily. Water samples (5 mL)
were collected using a pipette from the center of each tank.
2.5. Fish blood plasma and gill sampling
After exposure, ﬁsh were anaesthetized with MS-222 (500 mg/L
buffered with 1 M sodium bicarbonate to pH 7.4 and aerated) and
humanely sacriﬁced according to UK Home Ofﬁce procedures. Fish
were immediately wet weighed (g) and the standard length
measured (mm). Each ﬁsh was terminated by removal of the brain
and the tail removed using a scalpel to collect blood into a hepa-
rinized micro-capillary tube (Fisher Scientiﬁc, Loughborough, UK).
The tubes were sealed at one end and centrifuged (12,300  g,
4 min, 20 C) to separate the plasma, which was stored on ice prior
to chemical analysis. The gill ﬁlaments were dissected, separated
into two tubes, snap frozen in liquid nitrogen and stored at 80 C.
2.6. Chemical analysis of water and ﬁsh blood plasma
Ibuprofen concentrations were determined by reversed-phase
Liquid Chromatography coupled with tandem Mass Spectrometry
(LC-MS/MS) (see Appendix A). Initial chromatographic separation
was carried out on a Dionex Ultimate 3000 instrument using a
Gemini® NX C18 column (50  2.0 mm, 3 mm, Phenomenex, CA,
USA) maintained at 50 C. The mobile phase consisted of 0.1%
ammonia in water (eluent A) and 0.1% ammonia in methanol
(eluent B), delivered at a ﬂow rate of 500 mL/min. Ibuprofen was
detected using an Ion Trap mass spectrometer (LTQ, Thermo Sci-
entiﬁc, UK)with heated electrospray ionization. Datawere acquired
and processed using Xcalibur™ software (Thermo Scientiﬁc, UK).
An internal standard, ibuprofen-d3 (CAS No. 121662-14-4, 98%
purity; Sigma-Aldrich, Dorset, UK) was used for the quantiﬁcation
of ibuprofen in plasma samples (spiked with 80 mg/L ibuprofen-d3).
The samples were analyzed in duplicate.
2.7. Measurement of prostaglandin E metabolite (PGEM)
PGE2 metabolites in the gills were measured using the Prosta-
glandin E Metabolite EIA Kit (Cayman Chemical Company, Ann
Arbor, MI, USA). This kit converts unstable PGE2 metabolites into a
single, stable derivative (PGEM) that can be more easily quantiﬁed.
Brieﬂy, frozen gill tissues (~20 mg) were lysed in 500 mL of ho-
mogenization buffer (0.1 M phosphate, pH 7.4, 1 mM EDTA con-
taining 10 mM indomethacin to prevent ex vivo formation of
prostaglandins) using a tissue lyser (Tissue Lyser II, QIAGEN, Man-
chester, UK) and centrifuged (8000  g, 10 min, 4 C). Up to 120 mL
of the supernatant was removed for protein quantiﬁcation. The
remaining supernatant was incubated at 20 C for 60 min with
4  volumes of ice-cold acetone and centrifuged (400  g, 5 min,
room temperature) to pellet the protein. The supernatant was
transferred to a clean tube and the acetone was evaporated under
nitrogen. The samples were re-suspended in enzyme-
immunoassay buffer (0.1 M phosphate solution, pH 7.4, 0.1%
bovine serum albumin, 0.4 M NaCl, 1 mM EDTA and 0.01% sodium
azide). The PGEM standard solution (supplied in the kit) and
samples were derivatized overnight at 37 C. The PGEM concen-
tration in each sample (assayed in triplicate) was determined from
an 8-point standard curve (standards assayed in duplicate;
0.39e50 pg/mL). The curve regression coefﬁcient (r2) was 0.9559.The PGEM level was normalized against the sample protein con-
centration (mg/mL) determined using the QuantiPro™ bicincho-
ninic acid (BCA) assay (Sigma-Aldrich, Poole, UK), and is expressed
as pg/mg protein. Wild-type mouse lung tissue obtained from Dr
Pook's group, Brunel University London, was used as an additional
positive control to ensure correct sample preparation.
2.8. Measurement of cyclooxygenase (ptgs) gene expression
Total RNAwas isolated from gills (~20 mg) using the GenElute™
Mammalian Total RNA Miniprep kit (Sigma-Aldrich, Dorset, UK),
treated with DNase I (Sigma-Aldrich, Dorset, UK) and reverse
transcribed to cDNA using the iScript™ cDNA Synthesis Kit (Bio-
Rad Laboratories, Hertfordshire, UK). Nuclease-free water was
added to the RNA template as a negative control. Quantitative real-
time PCR (qPCR) was carried out using the ABI Prism® 7900 HT real-
time PCR instrument (Applied Biosystems, Life Technologies,
Paisley, UK). The primers used to amplify ptgs genes were designed
from template gene fragments that we previously isolated in the
fathead minnow (Suppl. Table S1). Each 25 mL PCR reaction con-
sisted of cDNA (50 ng/mL), 2 QuantiFast SYBR Green mastermix
(QIAGEN, Manchester, UK), forward and reverse primers (0.4 mM)
and nuclease-free water. The reactions were assayed in duplicate.
Nuclease-free water was added to the no-template (negative)
controls. Ampliﬁcation was carried out using the following cycling
conditions: initial denaturation at 95 C for 5 min, followed by 40
cycles at 95 C for 10 s and 60 C for 30 s. Melting curve analysis was
used to check the speciﬁcity of the primers, and the amplicons were
cloned and sequenced to conﬁrm their identities. The mRNA levels
of the ptgs genes were normalized against b-actin. Relative mRNA
expression was calculated using the comparative (2DDCt) method
(Livak and Schmittgen, 2001). The ampliﬁcation efﬁciency for each
primer pair was determined by the slope of the Ct standard curve.
2.9. Measured vs. modeled ﬁsh plasma concentrations
Measured plasma ibuprofen concentrations, from ﬁsh exposed
in the range-ﬁnder, were compared with plasma concentrations
modeled using the Fish Plasma Model (FPM) (Huggett et al., 2003),
based on the non-kinetic bioconcentration model proposed by
Fitzsimmons et al. (2001). The ﬁsh plasma concentration was
estimated using the Log Kow (3.80) reported by Brown et al. (2007)
(Eq. 1). Many pharmaceuticals are amenable to ionization at
different pH's and therefore use of the Log D (0.45 at pH 7.4, pre-
dicted using ACD/Labs, Toronto, ON, Canada) was also evaluated
(Eq. 2). The ﬁsh plasma concentration was calculated using the
measured water concentration over 96 h (Eq. 3).
LogPblood:water ¼ 0:73 LogKoctanol:water  0:88 (1)
LogPblood:water ¼ 0:73 LogD7:4  0:88 (2)
½Fish Plasma ¼ ½Measured Water  Pblood:water (3)
2.10. Statistics
Results are presented as mean ± standard deviation (sd). Sta-
tistical analysis and graphs were created using GraphPad Prism 6
(GraphPad Software, Inc). Statistical signiﬁcance was tested using
unpaired t-tests or one-way ANOVA followed by a multiple com-
parison test (at p < 0.05, p < 0.001 or p < 0.0001). The relationship
between plasma ibuprofen and PGEM level was examined using
regression analysis.
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3.1. Measured water and blood plasma ibuprofen concentrations
In the range-ﬁnder, the mean measured water concentrations
(over 96 h) were 105 ± 2, 278 ± 70, 409 ± 26 and 502 ± 56 mg
ibuprofen/L, which were close to the nominal values (105, 103, 111
and 101%, respectively, of 100, 270, 370 and 500 mg ibuprofen/L)
(Suppl. Table S2). Ibuprofen measurements in the water of SC tanks
were below the Limit of Detection (LOD;  2.5 mg/L). Ibuprofen
entered into fathead minnow blood plasma, but large inter-
individual variations were observed (Suppl. Table S3). The LOD
for ibuprofen measurements in the plasma of SC ﬁsh was 30 mg/L.
The mean plasma ibuprofen concentrations (over 3e96 h) in
fathead minnows exposed to nominal 100 and 500 mg/L were
657 ± 183 mg/L and 106,047 ± 71,291 mg/L, respectively. The mean
plasma ibuprofen concentrations in ﬁsh exposed to nominal 270
and 370 mg/L (over 24e96 h) were 14,409 ± 22,084 mg/L and
40,540 ± 36,100 mg/L, respectively, closer to the human therapeutic
plasma concentrations (Cmax; 15,000e30,000 mg/L) (Schulz et al.,
2012).
Therefore, the nominal water concentration of 350 mg/L was
selected as a suitable exposure concentration for obtaining the Cmax
in ﬁsh in the subsequent experiments.
In the second experiment, ﬁsh were exposed to the mean
measured water concentration (over 24e72 h) of 370 (368 ± 4) mg
ibuprofen/L (105% of nominal concentration of 350 mg/L) (Suppl.
Table S2). This resulted in a mean plasma ibuprofen concentration
of 8370 ± 5456 mg/L, which was 1.8-fold below the lowest Cmax
(15,000 mg/L).
In the third experiment, ﬁsh were exposed to mean measured
water concentrations (over 24e72 h) of 9 (±1) mg ibuprofen/L and
470 (473 ± 9) mg ibuprofen/L (181% and 135% of their respective
nominal concentrations of 5 and 350 mg ibuprofen/L). This was a
static water exposure and the discrepancy between the nominal
and measured water concentrations was due to a dilution error.
These water concentrations resulted in mean plasma ibuprofen
concentrations of 67 ± 22 mg ibuprofen/L and 2680 ± 1605 mg
ibuprofen/L, and were 224-fold and 5.6-fold below the lowest Cmax,
respectively.
It is unclear why exposure to 470 mg ibuprofen/L resulted in a
lower (mean) plasma ibuprofen concentration than exposure to
370 mg ibuprofen/L (2680 vs. 8370 mg ibuprofen/L). However, even
though the mean plasma ibuprofen concentrations were different
in the two experiments, there was some overlap as a consequence
of the high ﬁsh-to-ﬁsh variability and unequal sample sizes (n ¼ 12
vs. n ¼ 40). The difference in the plasma concentrations could also
be related to the static exposure regime utilized in the third
experiment, as opposed to the ﬂow through regime used in the
previous experiments. However, the water (exposure) concentra-
tions measured in the static experiment were generally stable (but
higher than expected, due to a dilution error, as previously stated)
over the 72 h (467 mg/L, 484 mg/L and 469 mg/L at 24, 48 and 72 h,
respectively). The weight of the ﬁsh in the static experiment was
slightly lower (but not signiﬁcantly) than in the range-ﬁnder and
experiment 2. The biomass of ﬁsh (g/L) in the SC, 5 and 350 mg
ibuprofen/L tanks was 0.47, 1.0 and 1.1 g/L, respectively.
Hereafter, concentrations are expressed as nominal for the
range-ﬁnder, and measured for the second (370 mg ibuprofen/L)
and third experiments (9 and 470 mg ibuprofen/L) (as measured
concentrations were more than 20% above the nominal).
3.2. PGEM levels in fathead minnow gill tissues
The mean PGEM level (14 ± 12.5 pg/mg) was signiﬁcantlydecreased (p ¼ < 0.0001) in the gills of fathead minnows exposed,
for 72 h, to 370 mg ibuprofen/L (experiment 2), when compared to
the SC (106 ± 80 pg/mg) (Fig. 1a). To determine if the effects on
PGEM could be replicated, and if an effect could be seen at a water
concentration that was not expected to produce the effective ﬁsh
plasma concentrations, fathead minnows were exposed to
(measured) 9 mg ibuprofen/L (and 470 mg ibuprofen/L) over 24e72 h
(experiment 3; data from exposed ﬁsh at 48 h not presented).
The mean PGEM level (884 ± 540 pg/mg) was not signiﬁcantly
different (p ¼ 0.30) in the gills of ﬁsh exposed to 9 mg ibuprofen/L,
when compared to the SC (609 ± 635 pg/mg) (Fig. 1b). The mean
PGEM level (29 ± 30 pg/mg) was signiﬁcantly decreased (p¼ 0.005)
in the gills of ﬁsh exposed to 470 mg ibuprofen/L, when compared to
the SC, and 9 mg ibuprofen/L (p < 0.0001) (Fig. 1b).
The PGEM levels were highly variable in the SCs (ranging be-
tween 10 and 248 pg/mg and 120e1680 pg/mg in the two experi-
ments) and in the exposed groups (between 0.4- 62 and 1.9e89 pg/
mg in the 370 and 470 mg ibuprofen/L groups, respectively).
Fig. 1c demonstrates that the PGEM level was signiﬁcantly
decreased (p ¼ 0.001) between 24 and 72 h in ﬁsh exposed to
470 mg ibuprofen/L, indicating a time-dependent effect, similar to
that which occurs in humans. There was no signiﬁcant difference
(p¼ 0.9) in PGEM level between 24 and 72 h in ﬁsh exposed to 9 mg
ibuprofen/L.
3.3. The relationship between plasma ibuprofen and PGEM levels
A dose-response between plasma ibuprofen and PGEM levels
was seen between ﬁsh exposed to 9 mg ibuprofen/L (no mode-of-
action related response) and 370 and 470 mg ibuprofen/L (mode-
of-action related response observed) (Fig. 2). However, there was
no clear relationship between the plasma ibuprofen and the
magnitude of the effect (i.e. amount of PGEM inhibition) in ﬁsh
exposed to 370 and 470 mg ibuprofen/L (r2 ¼ 0.01).
The PGEM levels in ﬁsh exposed to 9 mg ibuprofen/L were similar
to the PGEM levels measured in the SC ﬁsh, when the mean plasma
ibuprofen concentration (67 mg/L) was 224-fold below the lowest
Cmax. Decreased PGEM levels were seen in ﬁsh exposed to 370 and
470 mg ibuprofen/L, when the mean plasma ibuprofen concentra-
tion was 1.8e5.6 fold below the lowest Cmax. The reduced PGEM
levels were observed in ﬁsh with plasma ibuprofen concentrations
spanning over 30-fold (from 710 to 22,000 mg ibuprofen/L). These
results demonstrate that ibuprofen can inhibit PGEM levels over a
range of plasma concentrations, including concentrations up to 21-
fold below the lowest Cmax.
There was large inter-individual variation in plasma ibuprofen
(30-fold, 710e22,000 mg/L) and PGEM levels (~50-fold, 2.4e118 pg/
mg). The PGEM levels were also highly variable in the SC ﬁsh (~170-
fold, 10e1680 pg/mg).
3.4. Cyclooxygenase (ptgs) gene expression in gill tissues
We identiﬁed three isoforms of ptgs genes in the fathead
minnow, a situation similar to that in zebraﬁsh (Ishikawa et al.,
2007). In experiment 2, the mean expression of ptgs 1 was un-
changed in gills of exposed ﬁsh (compared to SC ﬁsh), whereas the
ptgs 2a and ptgs 2b genes trended towards up-regulation, with ptgs
2b being close to signiﬁcance (p values ¼ 0.10, 0.12 and 0.07,
respectively) (Suppl. Figure S1).
To establish if there was a dose-response between gene
expression and drug plasma concentration, ptgs gene expression in
gills and plasma ibuprofen in exposed ﬁsh was also examined;
however, no correlation was observed (Suppl. Figure S2), nor be-
tween ptgs gene expression and PGEM levels in gills (Suppl.
Figure S3).
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Fig. 1. Prostaglandin E metabolite (PGEM) levels in the gills of fathead minnows
exposed to solvent (SC) and ibuprofen. Fish were exposed to (a) SC (n ¼ 10) and
370 mg/L (n ¼ 40) for 72 h and (b) SC (n ¼ 9), 9 mg/L (n ¼ 12) and 470 mg/L (n ¼ 12) for
24, 48 (SC ﬁsh only) and 72 h (data combined). In (c), data from 9 and 470 mg/L are
shown for 24 or 72 h (n ¼ 6 for each time point for each concentration). Each dot
represents an individual ﬁsh within the treatment group, along with the mean ± sd.
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The FPM, modeled using Log Kow, over-estimated the plasma
ibuprofen concentration by 12-fold at 100 mg ibuprofen/L and
under-estimated the plasma ibuprofen concentration by 3-fold at
500 mg ibuprofen/L (Fig. 3). The FPM most accurately estimated the
plasma ibuprofen concentration at 270 and 370 mg ibuprofen/L, the
concentrations at which the Cmax was reached. The FPM severely
under-estimated the plasma ibuprofen concentration in ﬁsh at all
tested water concentrations when the Log D7.4 was used.
4. Discussion
The aim of this study was to assess the validity of the read-
across hypothesis, by examining the effects of ibuprofen on ﬁsh.
We addressed the criteria of the read-across hypothesis, as outlined
by Rand-Weaver et al. (2013), and conﬁrmed the water concen-
tration(s) and blood plasma concentration(s) of ibuprofen, linked
the exposure to a speciﬁc mode-of-action biological effect expected
at the Cmax (by measuring PGEM, surrogate marker for PGE2), and
demonstrated that this effect was seen at plasma concentrations
similar to (1.8- to 5.6-fold below) the lowest Cmax (15,000 mg/L). In
humans, the therapeutic effects of ibuprofen (i.e. perceptible pain
relief) have been reported at plasma ibuprofen levels of
6800e10,100 mg/L (20 min post 400 mg dosing), and maximal pain
relief was conﬁrmed at 30 min, when plasma levels were
14,800e18,900 mg/L (Mehlisch and Sykes, 2013). These ﬁndings
suggest that the on-set of therapeutic effects can occur at blood
plasma concentrations below the stated Cmax (15,000e30,000 mg/L)
(Schulz et al., 2012), and may explainwhy the anticipated mode-of-
effect was observed in ﬁsh before the Cmax (peak plasma concen-
tration) was reached.
A mode-of-action related effect on PGEM was observed in
ibuprofen-exposed ﬁsh when the mean blood plasma concentra-
tion was 1.8- to 5.6-fold, but not 224-fold, below the lowest Cmax
(15,000 mg/L). These ﬁndings provide evidence in support of the
read-across hypothesis and demonstrate that pharmaceuticals can
exert similar target-mediated pharmacological effects in ﬁsh as
they do in humans, at similar blood plasma concentrations. Our
ﬁndings are consistent with the mode-of-action relevant behav-
ioral effects of sertraline and ﬂuoxetine reported in ﬁsh at plasma
concentrations similar to human therapeutic concentrations
(Margiotta-Casaluci et al., 2014; Valenti et al., 2012) and the effects
of the synthetic progestagen, levonorgestrel (Runnalls et al., 2015).
Collectively, these studies provide experimental evidence for the
read-across hypothesis, identiﬁed as lacking by Rand-Weaver et al.
(2013). In ﬁsh exposed to the lowest tested concentration (9 mg
ibuprofen/L), when the mean plasma ibuprofen concentration was
224-fold below the lowest Cmax, no mode-of-action effect on PGEM
levels was seen.
The mode-of-action of ibuprofen is related to its non-speciﬁc
inhibition of prostanoids, via the inhibition of the COX enzymes.
Consistent with our ﬁndings, the effects of ibuprofen on PGE2 levels
have also been demonstrated in zebraﬁsh (whole body homoge-
nates or ovaries), following 7-d exposure to 21e506 mg/L
(Morthorst et al., 2013) and in bluntnose minnows, following
exposure to 50 mg/L and 100 mg/L ibuprofen, which resulted in a
signiﬁcant reduction in gill PGE2 concentrations (Bhandari and
Venables, 2011). In the latter study, the lower (5 and 25 mg
ibuprofen/L) concentrations tested did not result in a signiﬁcant* indicates signiﬁcance level of p < 0.05, ** of p < 0.001 and *** of p < 0.0001. (Results
presented are from experiments 2 and 3; and are displayed as such so that the data
from every ﬁsh can be readily visualized).
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The effect of ibuprofen on PGEM reduction in ﬁsh exposed to 470 mg
ibuprofen/L was also more pronounced at 72 than 24 h. Such time-
dependency has not previously been reported in ﬁsh, but is in
agreement with data from humans (Giagoudakis and Markantonis,
2005; Rane et al., 1978; Rome and Lands, 1975).
Exposure to stressors can lead to pain and inﬂammation,
resulting in a proliferated increase in prostanoids, primarily PGE2
(Vane, 1971). PGE2, is chemically unstable and is rapidly converted
in vivo to several PGE metabolites (13,14-dihydro-15-keto PGE2 and
13,14-dihydro-15-keto PGA2) (Ferreira and Vane, 1967). For thisreason, blood and other animal or human samples often contain
very little intact PGE2. Therefore, in this study, the measurement of
PGE metabolites (PGEM) was used to provide an estimate of the
actual (parent) PGE2 production. We investigated only the primary
mammalian mode-of-action of ibuprofen, namely its ability to
inhibit PGE2 synthesis, and showed that ibuprofen acts via this
mode-of-action in ﬁsh also. The biological functions of PGE2 in ﬁsh
are not well characterized, and the consequences of prostanoid
inhibition in ﬁsh are presently unknown. However, prostanoids
have been implicated in several “homeostatic” functions in ﬁsh,
including reproduction (Fujimori et al., 2011; Gonçalves et al., 2014;
Lister and Van Der Kraak, 2008; Sorbera et al., 2001) glucose
metabolism (Busby, 2002) and immunity (Gomez-Abellan and
Sepulcre, 2016). Further work is necessary to investigate how
NSAIDs affect ﬁsh physiology and until those consequences are
known, it is not possible to develop a meaningful Adverse Out-
comes Pathway for this group of pharmaceuticals.
In this study, we examined the effect of ibuprofen on the PGEM
level in the gills, which we considered to be a suitable tissue for
examining mode-of-action effects. In our preliminary work (data
not shown) we alsomeasured the PGEM level in liver and brain (the
plasma was not used as it was required for chemical analysis).
However, due to the limited amount of starting material and lower
amounts of PGE2, the tissues had to be pooled (n ¼ 1), making any
effect very difﬁcult to ascertain. The PGEM level was easier to
measure in gill tissue, in agreement with the results of others
(Bhandari and Venables, 2011; Knight et al., 1995) who have re-
ported a higher abundance, and the most consistent measurable
levels of PGE2, in this tissue. However, as prostaglandin levels in
one tissue (gills) do not represent global levels in ﬁsh, further
studies should examine PGEM levels in blood plasma and other
tissues.
The PGEM levels were highly variably in solvent control and
ibuprofen-exposed ﬁsh. The variation in control groups suggests
that factors other than drug exposure can also modulate PGEM
production in “healthy” ﬁsh tissues. It is difﬁcult to pinpoint the
exact cause of such variation, since the controllable factors,
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the same handling and sampling procedures were used
throughout. It has been suggested that changes in dietary fatty
acids can result in extensive alteration in the proﬁle of prostanoids
in ﬁsh tissues (Norambuena et al., 2012). However, in this study, the
ﬁsh were not fed. We speculate that the variation observed in the
control ﬁsh may be normal and represents the natural variation in a
population of laboratory-bred fathead minnows. Further work is
needed to gain an understanding of the “expected level” of the
biological variation within a sample population. In order to reduce
the uncertainty in the data, the sample size (n) could be increased,
although it was reasonably high in the studies reported here.
There was a dose-response between plasma ibuprofen and
PGEM levels between ﬁsh exposed 9 mg/L and 370 or 470 mg/L.
However, as a consequence of testing only a limited number of
concentrations of ibuprofen (9, 370 and 470 mg/L), which were not
evenly distributed, it is not possible to know exactly where the
concentration-response relationship lies and what shape it would
take, and thus what type of regression analysis would best describe
that relationship. Given the large inter-individual variation in
plasma ibuprofen (30-fold, 710e22,000 mg/L) and PGEM levels (50-
fold, 2.4e118 pg/mg), there was only a 10-fold difference between
the lowest measured plasma concentration (710 mg/L) in the
370 mg/L exposure group, and the mean plasma level (67 mg/L) in
the 9 mg/L group. This indicates that there is a relatively narrow
margin between the plasma concentrations at which no PGEM
inhibition was observed, and at which PGEM was signiﬁcantly
decreased. Further work is needed to ascertain the lowest (water)
exposure concentration at which effects on PGEM would be seen
(i.e. between 9 and 370 mg/L).
The large inter-individual variation in plasma ibuprofen con-
centrations has a major impact on attempts to relate effective drug
plasma concentrations with target-mediated effects in ﬁsh, and can
be identiﬁed as a limitation of the read-across approach. Further
work is needed to identify the expected level of variation in drug
plasma concentrations, particularly in ﬁsh exposed to the same
concentration of a drug. Certainly, in humans, variability in drug
responses between individuals is well recognized (Wood, 2001),
and therefore drugs exert their therapeutic effects over a range of
concentrations (before adverse drug reactions occur) (Brune et al.,
2010). This variability is largely inﬂuenced by drug pharmacoki-
netics and pharmacodynamics (Derendorf et al., 2000; Reigner
et al., 1997; Sheiner and Steimer, 2000). For example, variations
in plasma protein binding can affect the distribution of bound and
free drug fractions in the body (Lin et al., 1987) and drug meta-
bolism can be inﬂuenced by the presence of genetic poly-
morphisms (García-Martín et al., 2004). Much less is known about
pharmacokinetics and pharmacodynamics in ﬁsh; for instance, the
drug plasma-protein binding kinetics (Owen et al., 2007) are nearly
always unknown. It is possible that differential plasma-protein
binding and/or drug distribution into other tissues may account
for why reduced (gill) PGEM levels were seen in ﬁsh with plasma
ibuprofen concentrations ranging over 30-fold. However, this is
only speculative. Another possible explanation is saturation of the
active sites of the COX protein following NSAID treatment, which
has been observed in rat models (Satterwhite and Boudinot, 1991).
Ibuprofen is a weak, competitive non-selective inhibitor of the COX
enzymes (Gierse et al., 1999), and therefore after 72 h of continuous
exposure, an increase in the plasma ibuprofen concentration
beyond a certain level (i.e. when all available active sites have been
occupied) possibly would have no further effect on PGEM
inhibition.
It is possible to use the relationship between plasma concen-
trations in humans (the Cmax), and in ﬁsh, in order to predict the
likelihood for similar pharmacological responses (Huggett et al.,2003; Rand-Weaver et al., 2013; Schreiber et al., 2011). The
plasma concentrations modeled using FPM (using the Log Kow)
accurately mirrored the measured plasma concentration in ﬁsh
exposed to 270 and 370 mg ibuprofen/L, and correctly predicted that
the Cmax would be reached at these water concentrations. These
ﬁndings are in agreement with other studies (Fick et al., 2010;
Margiotta-Casaluci et al., 2014; Nallani et al., 2016; Valenti et al.,
2012) that have used the FPM to accurately (within an order of
magnitude) predict the plasma concentrations of human pharma-
ceuticals in ﬁsh. In contrast to our ﬁndings, a recent study found Log
D7.0 to be a better predictor of plasma bioconcentration in ﬁsh
(Nallani et al., 2016) However, in that study, ibuprofen only weakly
bioconcentrated (by 1.4-fold) into channel catﬁsh plasma after 7-
d exposure to measured water concentrations (314 ± 55 mg/L)
(Nallani et al., 2011), whereas we show higher concentrations of
ibuprofen accumulated in the plasma of fatheadminnows. The FPM
over (by 12-fold)- and under (by 3-fold)-estimated the plasma
concentrations in ﬁsh exposed to 100 and 500 mg/L ibuprofen,
respectively. It is not known why this was the case, however, po-
tential sources of inaccuracy may arise from factors such as drug
ionization, transporters, metabolism, excretion and/or plasma
protein binding kinetics on drug uptake/plasma concentration. For
example, the presence of steroid hormone binding globulins in
teleost ﬁsh gills (Miguel-Queralt and Hammond, 2008) may in-
crease the uptake rate of steroid pharmaceuticals above that pre-
dicted by the FPM. Despite the growing support for the use of the
FPM, further experimental studies are still required in order to
evaluate how well the concentration of a pharmaceutical in ﬁsh
blood plasma can be theoretically modeled for a given water
concentration.
The mammalian COX enzymes are encoded by the ptgs 1 and
ptgs 2 genes. The additional ptgs 2 (2a and 2b) gene identiﬁed in the
fathead minnow is likely a result of genome duplication in teleost
ﬁsh (Havird et al., 2008). The expression levels of all ptgs genes
were not signiﬁcantly different between control and exposed ﬁsh
(Suppl. Figure S1), although there was a trend towards up-
regulation of the ptgs 2 genes (p ¼ 0.07 for ptgs 2b). This result is
in agreement with those of other studies reporting little or no
transcriptional change in ptgs gene expression in zebraﬁsh exposed
to ibuprofen (Ji et al., 2013; Morthorst et al., 2013). In contrast,
rainbow trout exposed for two weeks to 1.6e81.5 mg diclofenac/L
(1.5e88% of the Cmax) had global hepatic gene expression changes
consistent with the mode-of-action of NSAIDs (Cuklev et al., 2011).
At plasma concentrations close to the Cmax, a number of genes
functionally associated with inﬂammation and the immune
response were differentially regulated in the liver, and the hepatic
expression of the ptgs 1 and ptgs 2 genes was down-regulated.
However, the lack of a concentration-related response raises
questions about these results (Harris et al., 2014). In our study, the
gene expression levels were highly variable between individual
ﬁsh, and no relationship between gill ptgs expression and plasma
ibuprofen was observed, suggesting that this is not a suitable
biomarker for ibuprofen exposure. Given the lack of knowledge of
what inﬂuences gene expression and the sensitivity of this as an
end-point, more research is required before robust conclusions can
be reached regarding the relationship between the expression of
the ptgs genes and their product, the COX enzyme.
Ibuprofen has been reported in UK surface waters and ﬁnal ef-
ﬂuents at typical mean concentrations of 74 ng/L (Kasprzyk-
Hordern et al., 2009) and 2.48 mg/L (Gardner et al., 2012), respec-
tively. In this study, the 370 and 470 mg ibuprofen/L water con-
centrations produced plasma ibuprofen concentrations in ﬁsh
closest to the Cmax and induced the anticipated mode-of-action
related effect. Thus, this effect occurred at a water concentration
between 190 and 6300-fold higher than the environmental
A. Patel et al. / Chemosphere 163 (2016) 592e600 599concentration. However, in reality, pharmaceuticals exist as com-
plex mixtures (Sumpter, 2009; Vasquez et al., 2014), and there may
be several prostanoid inhibitors present in the ng to mg/L range.
Therefore, the potential for additive effects exist.
5. Conclusions
We demonstrate a mode-of-action related response on PGEM
levels in ﬁsh exposed to ibuprofen, at blood plasma concentrations
similar to those effective in humans. This study adds to an
increasing body of research supporting the read-across hypothesis
and FPM. However, we also highlight the importance of using large
sample sizes, as large inter-individual variation was observed.
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